MEDICILON

contact us jpkrencn

お知らせ

企業動向

あなたはここにいる:ホーム > お知らせ > 企業動向 > Medicilons VP of Bio...

Medicilons VP of Biology was awarded Outstanding Contribution in Reviewing

著者:   アップロード:2016-02-23  閲読回数:

    Biochemical Pharmacology granted Dr. Jun Wang, Medicilon’s VP of Biology, an “Outstanding Contribution in Reviewing” in recognition of the contribution made to the quality of the journal by Dr. Wang.  Dr. Wang has served as Editorial Advisory Board since 2010.




    Biochemical Pharmacology is a peer-reviewed medical journal published by Elsevier. It covers research on the pharmacodynamics and pharmacokinetics of drugs and non-therapeutic xenobiotics.  The latest Impact Factor (IF) of Biochemical Pharmacology is 5.009.  The IF of an academic journal is a measure reflecting the average number of citations to recent articles published in that journal. It is frequently used as a proxy for the relative importance of a journal within its field, with journals with higher impact factors deemed to be more important than those with lower ones.

上の:Medicilon Boston Office Officially Opened

下に:Chemical & Engineering News C&EN, Reforming Drug Approval in China